Liposome Manufacturing Market Emerging Trend, Opportunities, Key...

Liposome Manufacturing Market Emerging Trend, Opportunities, Key Players, Huge Growth, Revenue Analysis, 2023-2035

Posted 2025-02-06 10:28:51

Liposomes are small, artificial and lipid-based bilayered spherical vesicles, which are created spontaneously by hydrated phospholipids.

The global liposome manufacturing market size is estimated to reach USD 2.34 billion by 2035, growing at a CAGR of 9.7% during the forecast period.

Liposomes are artificial vesicles that carry the potential to be used as an effective drug delivery and model membrane system. During our research, we identified 72 players that provide services for the development and manufacturing of liposomes.

Majority of the players (33%) offering liposome development and manufacturing services were established post-2010. This is indicative of the growing interest of stakeholders in this domain. Examples of some recently established players, include (in reverse chronological order of year of establishment; established post-2017) Amerigo Scientific (2020), DIANT Pharma (2019), GMPriority Pharma (2019), Supplement Manufacturing Partners (SMP Nutra) (2019), and S G Biopharm (2018). This is followed by 25% of the companies established between 2001-2010.

Further, the current market landscape is dominated by the presence of mid-sized companies (37%), which represent more than 35% of the total number of players in this domain. Notable examples of mid-sized players that provide services for liposome development and manufacturing, include (in alphabetical order, no selection criteria) Ardena, BJP Laboratories, Creative Biolabs, Eurofins Advinus, GP Pharm, and Polymun Scientific.

As is evident from the figure, 74% of the players offer services for liposome formulation development, followed by the players which offer analytical method development (65%) and contract manufacturing services (64%). Further, 61% of the companies provide services for the process development of liposomes. Examples of some companies offering formulation development, contract manufacturing, analytical method development and process development services for liposomes, include (in alphabetical order, no selection criteria) Althea, BSP Pharmaceuticals, Creative Biostructure, Exelead, GP Pharm, and Polymun Scientific.

Further, majority of the liposome development and manufacturing service providers (58%) use stability analysis method for the quantification of liposomes, followed by the players that employ encapsulation efficiency determination method (43%). It is worth highlighting that liposome stability during storage or processing in the human body are two key considerations in liposome design and application, when using liposomes as drug carriers. Examples of players employing stability analysis method for liposomes, include (in alphabetical order, no selection criteria) Amerigo Scientific, BOC Sciences, Empirial Labs, and Etico Lifesciences.

Presently, most of the liposome development and manufacturing service providers (68%) offer services for discovery / research purposes. Examples of such companies, include (in alphabetical order, no selection criteria) Ardena, Corden Pharma, Curia, and Esco Aster. This is followed by service providers (53% each) offering services across preclinical and clinical scale of operation. Notable examples of such companies, include (in alphabetical order, no selection criteria) Althea, Biofuture Medicine and GP Pharm. It is worth mentioning that companies namely, (in alphabetical order, no selection criteria) Avanti Polar Lipids, Charles River Laboratories and Piramal Pharma Solutions, offer services across all (discovery / research, preclinical, clinical, and commercial) scales of operation.

Research Methodology

Our analysts have performed an accurate examination of the various aspects of the global market leveraging avant-garde primary and secondary sources of data collection. The report has gathered the necessary data and information from several reliable sources. Additionally, the report offers many strategic recommendations for companies involved in this ever-growing business sector to help them attain a competitive edge in the Liposome Manufacturing Market.

Thank you for reading our report. Kindly get in touch with us to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/liposome-manufacturing-market.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide.

Contact:

Roots Analysis

+1 (415) 800 3415

Sales@rootsanalysis.com